Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Chlordiazepoxide

Strength:
5 mg, 10 mg, 25 mg

Form: Capsules

Reference Brands: Librium®(US); Tropium®, Libritabs®(EU)

View More Get Enquiry

Zolpidem

Strength:
Sublingual tablets: 1.75 mg, 3.5 mg, 5 mg, 10 mg; Oral spray (US): 5 mg/spray

Form: Sublingual tablets, Oral Spray(US only)

Reference Brands: Zolpidem and Generics

View More Get Enquiry

Zolpidem

Strength:
IR: 5 mg, 10 mg; ER: 6.25 mg, 12.5 mg;

Form: Tablets

Reference Brands: Ambien®, Ambien CR®, Edluar®, Zolpimist®, Intermezzo®(US); Stilnoct®, Edluar®(EU)

View More Get Enquiry

Cabergoline

Strength:
0.25 mg, 0.5 mg

Form: Tablets

Reference Brands: Dostinex®, Cabaser®

View More Get Enquiry

Levodopa + Carbidopa

Strength:
IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg

Form: Tablets

Reference Brands: Sinemet®(US & EU); Rytary®, Parcopa®, Duodopa®

View More Get Enquiry

Pramipexole

Strength:
ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg

Form: Tablets

Reference Brands: Mirapex®(US), Sifrol® (EU)

View More Get Enquiry

Glucagon

Strength:
1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View More Get Enquiry

Insulin (Iv)

Strength:
100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View More Get Enquiry

Flumazenil

Strength:
0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View More Get Enquiry

Naloxone

Strength:
0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View More Get Enquiry

Nitroprusside

Strength:
50 mg/2 mL vial

Form: Intravenous (IV) injection

Reference Brands: Nitropress®(US), Nitroprussiat Ferrlecit®(EU)

View More Get Enquiry

Nitroglycerin (Iv)

Strength:
5 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) infusion solution

Reference Brands: Tridil®(US); Perlinganit®(EU)

View More Get Enquiry

Furosemide (Iv)

Strength:
10 mg/mL

Form: Intravenous (IV) injection

Reference Brands: Lasix®(US & EU)

View More Get Enquiry

Human Albumin

Strength:
5% solution: 5 g/100 mL; 20% solution: 20 g/100 mL

Form: Intravenous (IV) infusion solution

Reference Brands: US: Albutein®, Albuminar®, Flexbumin®; EU: Human Albumin Grifols®, Alburex®

View More Get Enquiry

Tranexamic Acid

Strength:
500 mg, 650 mg

Form: Tablets

Reference Brands: Lysteda®(US)

View More Get Enquiry

Tranexamic Acid

Strength:
100 mg/mL in 5 mL, 10 mL, or 100 mL vials

Form: Intravenous (IV) injection

Reference Brands: Cyklokapron®(US & EU)

View More Get Enquiry

Enoxaparin

Strength:
prefilled: 20 mg/0.2 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/1 mL

Form: Subcutaneous injection

Reference Brands: Lovenox®(US); Clexane®(EU)

View More Get Enquiry

Heparin (Ufh/Lmwh) Injections (Iv/Sq)

Strength:
UFH: 1,000 – 10,000 units/mL; LMWH: 20 mg/0.2 mL, 40 mg/0.4 mL, 60 mg/0.6 mL, 80 mg/0.8 mL, 100 mg/mL

Form: IV injection, SQ Injection

Reference Brands: UFH- Heparin Sodium; LMWH- US: Lovenox®, Fragmin®, EU: Clexane®, Fraxiparine®, Enoxaparin Teva

View More Get Enquiry

L-Alanyl-L-Glutamine

Strength:
20% solution (200 mg/mL)

Form: Sterile intravenous (IV) infusion solution

Reference Brands: Dipeptiven®(EU & Global)

View More Get Enquiry

Amino Acids Infusion

Strength:
5%, 8.5%, 10%, 15% solutions

Form: Intravenous (IV) Infusion Solutions

Reference Brands: Aminosyn®, Travasol®(US); Aminoplasmal®, Vamin®(EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.